Intensive versus moderate lipid lowering with statins after acute coronary syndromes - Wikidata - wikimedia - TriplyDB

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

http://www.wikidata.org/entity/Q29619716

about

Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction Preoperative statin therapy for patients undergoing cardiac surgery Statins for acute coronary syndrome Preoperative statin therapy for patients undergoing cardiac surgery Statins for acute coronary syndrome Statins for acute coronary syndrome Klf15 deficiency is a molecular link between heart failure and aortic aneurysm formation Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial Jupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?Ezetimibe therapy: mechanism of action and clinical update Standards of medical care in diabetes--2012 Pleiotropic effects of statins Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI ...Management of dyslipidaemia Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]Assessing compliance of cardiologists with the national cholesterol education program (NCEP) III guidelines in an ambulatory care setting The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.Plant sterols: factors affecting their efficacy and safety as functional food ingredients Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]Statins research unfinished saga: desirability versus feasibility Evidence-based prescribing of statins: a developing world perspective.Preoperative statin therapy for patients undergoing cardiac surgery Stabilization of high-risk plaques The relationship between Lp(a) and CVD outcomes: a systematic review Comparative effectiveness research and its utility in In-clinic practice Impact of treatment with rosuvastatin and atorvastatin on cardiovascular outcomes: evidence from the Archimedes-simulated clinical trials Statins in Acute Ischemic Stroke: A Systematic Review Acute management of unstable angina and non-ST segment elevation myocardial infarction Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies Pleiotropic effects of statins Statins: Cholesterol guidelines and Indian perspective Lipid-lowering therapy: who can benefit?The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment Statins: definitive translational research Statins in heart failure: do we need another trial?Use of atorvastatin in lipid disorders and cardiovascular disease in Chinese patients A novel therapeutic effect of statins on nephrogenic diabetes insipidus Method of LDL cholesterol measurement influences classification of LDL cholesterol treatment goals: clinical research study

P2860

Q21246041-D6C212D3-1F12-4D30-A527-6D07BE617708 Q24187896-ACC2D8A2-87B8-431C-96D9-A16ABAAF6641 Q24193862-46B431F2-24E4-4D58-989C-CC5A305DA676 Q24200475-489B3142-6376-482C-BD2F-5E299A1E4DD5 Q24236697-AA4CC656-9B15-4079-80B8-3DE2499B09E3 Q24243557-A4749675-5BAD-403B-8F14-A3A16D7C1CDD Q24306115-2CD80DB0-C8C8-4474-96CC-05F70678D1A8 Q24569666-8BE9BF07-A5DD-45EF-B3FE-ED070C596D5A Q24630160-14FD1870-19AA-40BB-B98A-4B2EF3C9B1AA Q24630302-B13917A8-C2D4-4410-9E95-D065FE1E4C0C Q24632533-FF4D77A7-B579-4BB9-9379-7C9208031CCB Q24647863-A759100B-831E-4FCE-BAB0-4E9BAEE53640 Q24650533-B55EF6DF-D798-4D6F-ACC6-810A76023C86 Q24650933-7924A504-1B78-4C8B-99CF-CA7CFD6B40F0 Q24673745-FB69DB24-EE78-4C96-A5EC-280AE1D7D2D2 Q24792952-EF6F4AEA-D73B-4859-8CCF-A0DB45C548D7 Q24793837-5EB01693-A91E-4408-8879-625D8ED84592 Q24794337-2B5CFD15-1BBD-4617-B5E6-137483F6F45C Q24796000-E7EEBBFF-FB7A-4D3D-ACAF-46FE902AC00C Q24803635-84FE6FCD-6156-4C13-A191-8FCA85622C8F Q24806340-6404F3E6-75F7-426D-B34B-636D76D317E8 Q24811267-2F872B45-69FE-4A52-964F-ED462272FA2B Q25255887-74AE132F-694D-474F-A1E1-2A8029551803 Q26472003-E486128D-7202-4070-B346-0EBF00D8C094 Q26738584-D05B13FF-72B1-4E66-B127-02BE2083C114 Q26749317-D58AD1BB-0715-4EE1-944C-E89F008EA9BF Q26767184-14001957-57E7-4BC8-A14F-C39F13E2EC23 Q26776293-B927D815-D2BD-49A0-8E05-B2AA896E039B Q26781913-ED7FDE85-C373-4846-BEA2-73C170E5FEDC Q26783157-FBD2D280-380B-4624-813C-EFD62FE4E3AB Q26783206-DADD7E26-6D23-4DC7-AE6C-DE523399F499 Q26783220-36A51042-5072-4A00-9F58-4D809CDF8ABA Q26783226-62CEF294-7D0C-4ADC-9AA6-FE5075A33578 Q26827432-F1500833-4204-43F2-BA3C-BE6ED1ACD8C0 Q26830602-56E75E52-D5B8-4E0B-B93B-010EAEEFD83A Q26851528-081D1C9C-D714-4303-9B45-E56365E73F62 Q26998966-E7D71158-0B9F-4F97-9CE4-8919ADAD57C1 Q27003173-926D4E1B-18AE-4030-81FB-591308CF68F3 Q27005638-25E05C5C-CC3D-4D74-8AD6-B05AA08E60C5 Q27687752-3B6C2C42-5A7D-4711-B355-9A69EC9B26C1

P2860

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

http://www.wikidata.org/entity/Q29619716

description

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2004

@ast

im April 2004 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 8 April 2004)

@en

wetenschappelijk artikel (gepubliceerd op 2004/04/08)

@nl

наукова стаття, опублікована у квітні 2004

@uk

مقالة علمية (نشرت في 8-4-2004)

@ar

name

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

@ast

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

@en

type

label

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

@ast

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

@en

prefLabel

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

@ast

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

@en

P1433

Q29619716-BBF2F506-40AD-433A-8070-66FEA0063A23

P1476

Q29619716-D74A101C-011C-40AB-B843-DAEEB1D6F700

P2093

Q29619716-10F09F72-43B0-40AB-92BD-346EF935CC80

Q29619716-1E64EF91-CC60-42D6-B28E-BF242D32CCBB

Q29619716-29D20AE0-9949-43E7-B86D-84E0F3E216A9

Q29619716-305A9465-567D-417E-B405-B9B106B67EA3

Q29619716-3FA20DE3-02BD-4CB0-B2E4-A63BEA89F097

Q29619716-4CC6A665-79A7-4670-8F8A-519372AF0103

Q29619716-672840AB-4965-4478-B3BD-F8B1E3A2645F

Q29619716-D7C676DC-91E5-4DBF-860D-5634CAEEE5DD

Q29619716-D9828C64-F655-40C0-A9C9-6CBF1486D493

Q29619716-E7E7F001-97ED-4FB1-A427-0EB08F7E45A9

P304

Q29619716-74D24519-0C8F-45DA-AD26-3F45E3B52A77

P31

Q29619716-A1DCC8ED-5C6C-4E43-A662-C14DBA410F92

P3181

Q29619716-D18F175F-060D-4908-BA51-8F0316E6CD9F

P356

Q29619716-2560C5BB-C285-4D89-B98B-11BF10FE923A

P407

Q29619716-0F790E08-1FE7-436A-8C3E-01B102CEE79E

P433

Q29619716-FD1BF18C-3E3E-4724-8333-1260730F704B

P478

Q29619716-0B85D687-EBD9-4045-97DC-C2667E9A1B40

P577

Q29619716-E5EEB939-4E2A-4935-AA52-89A93A75A4DA

P698

Q29619716-59AAF28F-D84D-41CF-B993-2A8E596C92AD

P3181

P356

P1433

The New England Journal of Medicine

P1476

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

@en

P2093

Belder R

http://www.w3.org/2001/XMLSchema#string

Braunwald E

http://www.w3.org/2001/XMLSchema#string

Cannon CP

http://www.w3.org/2001/XMLSchema#string

Hill KA

http://www.w3.org/2001/XMLSchema#string

Joyal SV

http://www.w3.org/2001/XMLSchema#string

McCabe CH

http://www.w3.org/2001/XMLSchema#string

Pfeffer MA

http://www.w3.org/2001/XMLSchema#string

Rader DJ

http://www.w3.org/2001/XMLSchema#string

Rouleau JL

http://www.w3.org/2001/XMLSchema#string

Skene AM

http://www.w3.org/2001/XMLSchema#string

P304

1495-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

120692

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA040583

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

350

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15007110

http://www.w3.org/2001/XMLSchema#string